Prof José-Manuel Carrascosa
Professor José-Manuel Carrascosa-Carrillo is the Head of the Department of Dermatology, Hospital Universitario Germans Trias i Pujol, Universitat Autònoma de Barcelona, Spain, and has been Associate Professor at the Universitat Autònoma de Barcelona since 2009. He earned his medical degree at the Hospital Clínic i Provincial de Barcelona, Universitat de Barcelona, in 1991 and his PhD degree at the Universitat Autònoma de Barcelona in 2006.
Professor Carrascosa-Carrillo is responsible for the Psoriasis, Phototherapy/Photobiology, Contact Dermatitis and Eczema Department and the Psoriasis Unit at the Hospital Universitario Germans Trias i Pujol. He has been Principal Investigator/Clinical Investigator in more than 60 research projects/clinical trials, many of them multinational, multicentre studies related to biological therapies in psoriasis and atopic dermatitis.
Professor Carrascosa-Carrillo has authored or co-authored 214 articles in journals on dermatology or other medical specialties. He was Editor-in-Chief of Actas Dermo-sifiliográficas from 2010 to 2014 and is currently a reviewer for several peer-reviewed journals, including Journal of Investigative Dermatology, The Lancet, Journal of the European Academy of Dermatology and Venereology, British Journal of Dermatology, Journal of Crohn's and Colitis, Journal of Dermatological Science and Biodrugs. He has been Chairperson at more than 100 local and international meetings and has been invited to give more than 250 lectures (national/ international) at conferences, symposia and other events. Professor Carrascosa is the Chair of the Spanish Group of Psoriasis of the Spanish Academy of Dermatology and vice-president of the Academia Española de Dermatología y Venereología (AEDV). Moreover, he has been a member of the scientific board of the Skin Inflammation & Psoriasis International Network (SPIN) since 2015 and was on the organising committee of the 2019 and 2022 SPIN meetings in Paris. He has been recently elected as a councillor of the International Psoriasis Council (IPC).
Exploring how the guidelines defines holistic care
Integrating holistic care through guideline recommendations with patient-reported outcomes and shared decision-making
Personalising the approach to HS care
Personalised HS care: Addressing the multi-faceted burden of HS with a case study example
Combination approaches in HS
The role of combined medical/surgical and medical-only treatments, including the optimal time for intervention
An overview of the European S2k guidelines
Key guideline updates including management algorithms for inflammatory and non-inflammatory HS phenotypes
Shared decisions: Redefining HS treatment
Prof. Prignano and Prof. Liakou discuss patient-reported outcomes, shared decision-making and multidisciplinary HS care
From guidelines to action: Transforming HS treatment pathways
Dr van der Zee and Prof. Arenbergerová explore holistic treatment of HS through medical, surgical and combined approaches